NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-058-1996-0-US-01 NUCLEIC ACID MOLECULES ENCODING THE TRANSCRIPTIONAL REPRESSOR GCF2 US 60/016,465 Abandoned
CC E-020-1996-0-US-01 IMAGE REGISTRATION USING VOXEL GRADIENTS WITH AN ITERATIVE REGISTRATION PROCESS US 60/016,429 Abandoned
NHLBI E-189-1993-0-US-06 FUSION PROTEINS CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN AND BACTERIAL PROTEIN AND EXPRESSION VEHICLES CONTAINING DNA ENCODING... US National Stage 08/549,760 Abandoned
NIAID E-101-1995-1-US-01 ISOLATED EPSTEIN-BARR VIRUS BZLF2 PROTEINS THAT BIND MHC CLASS II BETA CHAINS US CIP 08/430,633 5726286 Expired PDF
NCI E-117-1995-2-CH-09 ANTIVIRAL PROTEINS, DNA CODING SEQUENCES THEREFOR, AND USES THEREOF CH EP 96913854.4 Abandoned
NCI E-117-1995-2-EP-05 ANTIVIRAL PROTEINS, DNA CODING SEQUENCES THEREFOR, AND USES THEREOF EP National Stage 96913854.4 Abandoned
NCI E-117-1995-2-BE-08 ANTIVIRAL PROTEINS, DNA CODING SEQUENCES THEREFOR, AND USES THEREOF BE EP 96913854.4 Abandoned
NCI E-117-1995-2-DE-10 ANTIVIRAL PROTEINS, DNA CODING SEQUENCES THEREFOR, AND USES THEREOF DE EP 96913854.4 Abandoned
NCI E-117-1995-2-FR-11 ANTIVIRAL PROTEINS, DNA CODING SEQUENCES THEREFOR, AND USES THEREOF FR EP 96913854.4 Abandoned
NCI E-117-1995-2-GB-12 ANTIVIRAL PROTEINS, DNA CODING SEQUENCES THEREFOR, AND USES THEREOF GB EP 96913854.4 Abandoned
NCI E-117-1995-2-AU-02 ANTIVIRAL PROTEINS AND PEPTIDES, DNA, DNA-CODING SEQUENCES THEREFOR, AND USES THEREOF AU National Stage 56691/96 Abandoned
NCI E-117-1995-1-US-01 NUCLEIC ACIDS ENCODING ANTIVIRAL PROTEINS AND PEPTIDES, VECTORS AND HOST CELLS COMPRISING SAME, AND METHODS OF PRODUCING THE ANTIVIRAL PRO US CIP 08/638,610 5821081 Expired PDF
NCI E-117-1995-2-PCT-01 Antiviral Proteins, DNA Coding Sequences Therefor, and Uses Thereof PCT PCT COMB PCT/US96/05908 Abandoned
NCI E-117-1995-2-JP-06 ANTIVIRAL PROTEINS, DNA-CODING SEQUENCES THEREFOR, AND USES THEREOF JP National Stage 532778/1996 Abandoned
NIBIB E-101-1996-0-US-01 ULTRAFAST MR TEMPERATURE IMAGING US ORD 60/017,070 Abandoned
NCI E-117-1995-2-CA-04 ANTIVIRAL PROTEINS, DNA-CODING SEQUENCES THEREFOR, AND USES THEREOF CA National Stage 2219105 Abandoned
NIEHS E-080-1994-0-JP-07 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 JP National Stage 532754/96 Abandoned
NIEHS E-080-1994-0-AU-08 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 AU National Stage 55790/96 Abandoned
NIEHS E-080-1994-0-EP-06 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 EP National Stage 96913202.6 Abandoned
NIEHS E-080-1994-0-PCT-04 No_Patent_Title PCT PCT PCT/US96/05848 Abandoned
NIEHS E-080-1994-0-CA-09 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 CA National Stage 2219221 Abandoned
NIDCD E-228-1995-0-US-01 CONJUGATE VACCINE FOR NONTYPEABLE HAEMOPHILUS INFLUENZAE US 60/016,020 Abandoned
NIAID E-033-1996-1-EP-04 MODIFIED MYELIN BASIC PROTEIN MOLECULES EP National Stage 96913035.0 Abandoned
NIAID E-033-1996-1-GB-12 MODIFIED MYELIN BASIC PROTEIN MOLECULES GB EP 96913035.0 Abandoned
NIAID E-033-1996-1-DE-10 MODIFIED MYELIN BASIC PROTEIN MOLECULES DE EP 96913035.0 Abandoned
NIAID E-033-1996-1-FR-11 MODIFIED MYELIN BASIC PROTEIN MOLECULES FR EP 96913035.0 Abandoned
NIAID E-033-1996-1-KR-06 MODIFIED MYELIN BASIC PROTEIN MOLECULES KR National Stage 1019970707855 Abandoned
NHGRI E-005-1997-0-US-01 METHOD FOR SIMULTANEOUS DETECTION OF MULTIPLE FLUOROPHORES FOR IN SITU HYBRIDIZATION AND MULTICOLOR CHROMOSOME PAINTING AND BANDING US ORD 08/635,820 5817462 Expired PDF
NIAID E-033-1996-1-PCT-01 MODIFIED MYELIN PROTEIN MOLECULES PCT PCT COMB PCT/US96/005611 Expired
NIAID E-033-1996-1-AU-02 MODIFIED MYELIN BASIC PROTEIN MOLECULES AU National Stage 55658/96 Abandoned
NIAID E-033-1996-1-CA-03 MODIFIED MYELIN BASIC PROTEIN MOLECULES CA National Stage 2218858 Abandoned
NIAID E-033-1996-1-JP-05 MODIFIED MYELIN BASIC PROTEIN MOLECULES0 JP National Stage 8-533344 Abandoned
NCI E-087-1996-0-US-01 HETEROLOGOUS BOOSTING IMMUNIZATIONS FOR THE GENERATION OF CTL AND ANTITUMOR RESPONSES US 60/015,893 Abandoned
NIAID E-033-1996-1-MX-07 MODIFIED MYELIN BASIC PROTEIN MOLECULES MX National Stage 9708418 Abandoned
NCI E-088-1996-0-US-01 POINT MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES US ORD 08/635,344 Abandoned
NIAID E-082-1996-0-US-01 SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN US 60/015,642 Abandoned
NIA E-146-1993-0-US-02 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US FWC 08/633,185 5616608 Expired PDF
NIMH E-012-1991-6-US-01 METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS US 60/015,459 Abandoned
NCI E-061-1996-0-US-01 IN VITRO PROGNOSTIC TEST FOR PROGESSORS AND NON-PROGRESSORS AFTER HIV INFECTION US 60/015,492 Abandoned
NIMH E-012-1991-5-CA-05 METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS CA National Stage 2218166 Expired
NIMH E-012-1991-5-EP-07 Methods of Inducing Immune Tolerance Using Immunotoxins EP National Stage 96913790.0 Abandoned
NIMH E-110-1993-1-US-01 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US CIP 08/631,427 5811093 Abandoned PDF
NIMH E-012-1991-5-PCT-01 METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS PCT PCT COMB PCT/US1996/005087 Expired
NIA E-172-1996-0-US-01 USE OF FREE (F) PSA PROPORTION OF TOTAL (T) PSA TO SCREEN FOR PROSTATE CANCER (CaP) US ORD 08/631,031 Abandoned
NEI E-185-1992-5-US-01 NOVEL RECEPTOR FOR PIGMENT EPITHELIUM-DERIVED FACTOR US 60/015,304 Abandoned
NCI E-065-1996-0-US-01 ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS US 60/015,326 Abandoned
NIMH E-012-1991-5-AU-04 THYMIC TOLERANCE IN PRIMATES AU National Stage 56637/96 Abandoned
NCI E-196-1992-5-CA-04 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS CA National Stage 2216696 Abandoned
NCI E-182-1996-0-US-01 Phenylacetate and Derivatives Alone or in Combination with other Compounds Against Neoplastic Conditions and Other Disorders. US CON 08/633,833 5852056 Abandoned PDF
NCI E-196-1992-5-AU-03 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS AU National Stage 54483/96 Abandoned